Cargando…
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Parkinson’s disease (PD) is the second most common neurodegenerative illness majorly affecting the population between the ages of 55 to 65 years. Progressive dopaminergic neuronal loss and the collective assemblage of misfolded alpha-synuclein in the substantia nigra, remain notable neuro-pathologic...
Autores principales: | Naren, Padmashri, Cholkar, Anjali, Kamble, Suchita, Khan, Sabiya Samim, Srivastava, Saurabh, Madan, Jitender, Mehra, Neelesh, Tiwari, Vinod, Singh, Shashi Bala, Khatri, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473111/ https://www.ncbi.nlm.nih.gov/pubmed/36093711 http://dx.doi.org/10.3233/JAD-220682 |
Ejemplares similares
-
Microtubule acetylation dyshomeostasis in Parkinson’s disease
por: Naren, Padmashri, et al.
Publicado: (2023) -
Does skin permeation kinetics influence efficacy of topical dermal drug delivery system?: Assessment, prediction, utilization, and integration of chitosan biomacromolecule for augmenting topical dermal drug delivery in skin
por: Iyer, Akshaya, et al.
Publicado: (2021) -
Molecular encapsulation of andrographolide in 2-hydroxypropyl-β-cyclodextrin cavity: synthesis, characterization, pharmacokinetic and in vitro antiviral activity analysis against SARS-CoV-2
por: Singh, Shashi Chandrama, et al.
Publicado: (2021) -
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
por: Tryphena, Kamatham Pushpa, et al.
Publicado: (2023) -
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023)